Molecular minimal disease in remission predicts AML relapse
(HealthDay)—The detection of molecular minimal residual disease is associated with increased relapse rates in acute myeloid leukemia (AML), according to a study published in the March 29 issue of the New England Journal ...
Mar 29, 2018
0
3